Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 131-140 of 304 for heart disease

Edit search filters
  1. Behavior of Valve Leaflets

    Rochester, MN

  2. Invasive Hemodynamic Cardiopulmonary Exercise Testing for Assessment of Patients With Congenital Heart Disease

    Rochester, MN

  3. A Study to Evaluate the Safety and Effectiveness of GORE® CARDIOFORM Septal Occluder to Treat Migraine Headaches

    Scottsdale/Phoenix, AZ

  4. A Study to Evaluate the Edwards CLASP TR EFS in Tricuspid Regurgitation

    Rochester, MN

  5. Covered CP Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta

    Rochester, MN

  6. Phase I Safety and Feasibility Study of Intracoronary Delivery of Autologous Bone Marrow Derived Mononuclear Cells

    Rochester, MN

  7. A Study to Evaluate the Impact of Pre-Procedural Planning with 3D Printed Cardiac Models for Ventricular Assist Device Placement in Patients with Congenital Heart Disease

    Rochester, MN

  8. Safety and Potential Bioactivity of CLBS16 in Patients With Coronary Microvascular Dysfunction and Without Obstructive Coronary Artery Disease

    Rochester, MN

  9. Safety of Ataciguat in Patients with Moderate Calcific Aortic Valve Stenosis

    Rochester, MN

  10. A Study to See if Ultrasound Shear Wave Elastography Can Find Early Heart Muscle Damage from Chemotherapy in Cancer Patients

    Rochester, MN

.

Mayo Clinic Footer